“…Therefore, the use of recently reported intrabodies against small tags, such as SunTag (19aa) Degraded in absence of the antigen (GFP) (Tang et al, 2016) Lysine-less VHH4 (GFP, YFP, Venus) VHH4 in which lysines have been substituted for Arginines (Daniel et al, 2018) mCherry VHH (Fridy et al, 2014) MoonTag (gp41, 15aa linear epitope) (Boersma et al, 2019) BC2 VHH (BC2 tag, 12aa) Not tested as intrabody. (Braun et al, 2016) NbALFA (ALFAtag, 15aa) (Götzke et al, 2019) Darpin 3G86.32 Anti-GFP DARPin (GFP) (Brauchle et al, 2014) 2 m22 Anti-mCherry DARPin (mCherry) (Brauchle et al, 2014) E11 and G01 Anti-TFP DARPins (TFP) (Vigano et al, 2018) scFv HA frankenbody (HA, 9aa linear epitope) (Zhao et al, 2018) Suntag (GCN4 v4, 19aa linear epitope) Aggregation at high levels unless fused to sfGFP-GB1 scaffold (Tanenbaum, Gilbert, Qi, Weissman, & Vale, 2014) BGP7 ScFv (BGP7, 7aa linear epitope) (Lim, Ichinose, Shinoda, & Ueda, 2007;Wongso, Dong, Ueda, & Kitaguchi, 2017) (15aa), promises to be a great addition to the protein binder toolbox (Boersma et al, 2019;Gotzke et al, 2019;Tanenbaum et al, 2014;Zhao et al, 2018). In most cases, the short peptide tags recognized by these intrabodies has been used in multimerized form such as to recognize single protein particles; whether these short tags also work well when integrated as a single tag remains to be tested.…”